- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.35 | - |
NAV | ₹15.20 | - |
Fund Started | 18 Oct 2021 | - |
Fund Size | ₹216.51 Cr | - |
Exit Load | Exit load of 1% if redeemed within 12 months. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹500
-
Expense Ratio
2.35
-
NAV
₹15.20
-
Fund Started
18 Oct 2021
-
Fund Size
₹216.51 Cr
-
Exit Load
Exit load of 1% if redeemed within 12 months.
-
Returns
1 Year | 11.64% | - |
3 Year | 17.47% | - |
5 Year | - | - |
1 Year
11.64%
-
3 Year
17.47%
-
5 Year
-
-
Holding Analysis
Equity | 93.44% | - |
Cash | 6.56% | - |
Equity
93.44%
-
Cash
6.56%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 16.00% |
Lupin Ltd. | 6.34% |
Apollo Hospitals Enterprise Ltd. | 5.03% |
Divi's Laboratories Ltd. | 4.89% |
Suven Pharmaceuticals Ltd. | 4.88% |
Aurobindo Pharma Ltd. | 4.78% |
Max Healthcare Institute Ltd. | 4.05% |
Torrent Pharmaceuticals Ltd. | 3.85% |
Dr. Reddy's Laboratories Ltd. | 3.39% |
Alkem Laboratories Ltd. | 2.91% |
-
Fund Manager
Name | Dhimant Shah | - |
Start Date | 01 Dec 2022 | - |
Name
Dhimant Shah
-
Start Date
01 Dec 2022
-
About Fund
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. | - |
Launch Date | 18 Oct 2021 | - |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
-
Launch Date
18 Oct 2021
-
